Search results
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 7 days agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...
Studio Investment Management LLC Buys 2,236 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoStudio Investment Management LLC increased its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.1% during the 4th quarter, according to the company in its most ...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 6 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Merck Wins US Approval for Pneumonia Vaccine to Rival Pfizer’s
Bloomberg· 1 day agoMerck & Co. won US approval for a pneumococcal vaccine that threatens to unseat one of Pfizer Inc.’s...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via AOL· 6 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 7 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 1 day agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...